About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 634195, 11 pages
http://dx.doi.org/10.1155/2012/634195
Review Article

Role of Vitamin D in Insulin Resistance

1Division of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan
2Department of Pediatrics, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan
3Department of Medicine, Cardinal Tien Hospital, School of Medicine, Fu Jen Catholic University, New Taipei City 231, Taiwan

Received 15 June 2012; Revised 17 August 2012; Accepted 27 August 2012

Academic Editor: Hilton Kenji Takahashi

Copyright © 2012 Chih-Chien Sung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. F. Holick, “Resurrection of vitamin D deficiency and rickets,” The Journal of Clinical Investigation, vol. 116, no. 8, pp. 2062–2072, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Bouillon, “Vitamin D: from photosynthesis, metabolism, and action to clinical applicationseds,” in Endocrinology, L. J. DeGroot and J. L. Jameson, Eds., pp. 1009–1028, W.B. Saunders, Philadelphia, Pa, USA, 2001.
  3. H. F. DeLuca, “Overview of general physiologic features and functions of vitamin D,” The American Journal of Clinical Nutrition, vol. 80, no. 6, supplement, pp. 1689S–1696S, 2004.
  4. M. F. Holick, “Vitamin D deficiency,” The New England Journal of Medicine, vol. 357, pp. 266–281, 2007.
  5. K. A. Hruska, “Hyperphosphatemia and hypophosphatemia,” in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, M. J. Favus, Ed., pp. 233–242, American Society for Bone and Mineral Research, Washington, DC, USA, 6th edition, 2006.
  6. E. I. Christensen, O. Devuyst, G. Dom et al., “Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8472–8477, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Nykjaer, D. Dragun, D. Walther et al., “An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3,” Cell, vol. 96, no. 4, pp. 507–515, 1999. View at Scopus
  8. Y. Weisman, A. Harell, and S. Edelstein, “1α,25-Dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3in vitro synthesis by human decidua and placenta,” Nature, vol. 281, no. 5729, pp. 317–319, 1979. View at Scopus
  9. T. K. Gray, G. E. Lester, and R. S. Lorenc, “Evidence for extra-renal 1 α-hydroxylation of 25-hydroxyvitamin D3 in pregnancy,” Science, vol. 204, no. 4399, pp. 1311–1313, 1979. View at Scopus
  10. K. Stoffels, L. Overbergh, R. Bouillon, and C. Mathieu, “Immune regulation of 1α-hydroxylase in murine peritoneal macrophages: unravelling the IFNγ pathway,” Journal of Steroid Biochemistry and Molecular Biology, vol. 103, no. 3–5, pp. 567–571, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Esteban, M. Vidal, and A. Dusso, “1α-Hydroxylase transactivation by γ-interferon in murine macrophages requires enhanced C/EBPβ expression and activation,” Journal of Steroid Biochemistry and Molecular Biology, vol. 89-90, pp. 131–137, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Christakos, D. V. Ajibade, P. Dhawan, A. J. Fechner, and L. J. Mady, “Vitamin D: metabolism,” Endocrinology and Metabolism Clinics of North America, vol. 39, no. 2, pp. 243–253, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. H. L. Henry, “Regulation of vitamin D metabolism,” Best Practice and Research, vol. 25, no. 4, pp. 531–541, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. S. P. Daiger, M. S. Schanfield, and L. L. Cavalli Sforza, “Group specific component (Gc) proteins bind vitamin D and 25 hydroxyvitamin D,” Proceedings of the National Academy of Sciences of the United States of America, vol. 72, no. 6, pp. 2076–2080, 1975. View at Scopus
  15. A. Nykjaer, D. Dragun, D. Walther et al., “An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3,” Cell, vol. 96, no. 4, pp. 507–515, 1999. View at Scopus
  16. R. F. Chun, “New perspectives on the vitamin D binding protein,” Cell Biochemistry and Function, vol. 30, no. 6, pp. 445–456, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Mathieu and K. Badenhoop, “Vitamin D and type 1 diabetes mellitus: state of the art,” Trends in Endocrinology and Metabolism, vol. 16, no. 6, pp. 261–266, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. J. B. Zella and H. F. DeLuca, “Vitamin D and autoimmune diabetes,” Journal of Cellular Biochemistry, vol. 88, no. 2, pp. 216–222, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. S. A. Strugnell and H. F. Deluca, “The vitamin D receptor—structure and transcriptional activation,” Experimental Biology and Medicine, vol. 215, no. 3, pp. 223–228, 1997. View at Scopus
  20. M. R. Haussler, C. A. Haussler, L. Bartik et al., “Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention,” Nutrition Reviews, vol. 66, no. 2, pp. S98–S112, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. X. Palomer, J. M. González-Clemente, F. Blanco-Vaca, and D. Mauricio, “Role of vitamin D in the pathogenesis of type 2 diabetes mellitus,” Diabetes, Obesity and Metabolism, vol. 10, no. 3, pp. 185–197, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. A. G. Uitterlinden, Y. Fang, J. B. J. Van Meurs, H. A. P. Pols, and J. P. T. M. Van Leeuwen, “Genetics and biology of vitamin D receptor polymorphisms,” Gene, vol. 338, no. 2, pp. 143–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Jones, S. A. Strugnell, and H. F. DeLuca, “Current understanding of the molecular actions of vitamin D,” Physiological Reviews, vol. 78, no. 4, pp. 1193–1231, 1998. View at Scopus
  24. I. Nemere, Z. Schwartz, H. Pedrozo, V. L. Sylvia, D. D. Dean, and B. D. Boyan, “Identification of a membrane receptor for 1,25-Dihydroxyvitamin D3 which mediates rapid activation of protein kinase C,” Journal of Bone and Mineral Research, vol. 13, no. 9, pp. 1353–1359, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. A. S. Dusso, A. J. Brown, and E. Slatopolsky, “Vitamin D,” American Journal of Physiology, vol. 289, no. 1, pp. F8–F28, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. A. G. Pittas, J. Lau, F. B. Hu, and B. Dawson-Hughes, “Review: the role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis,” The Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 6, pp. 2017–2029, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Kendrick, G. Targher, G. Smits, and M. Chonchol, “25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey,” Atherosclerosis, vol. 205, no. 1, pp. 255–260, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Nagpal, S. Na, and R. Rathnachalam, “Noncalcemic actions of vitamin D receptor ligands,” Endocrine Reviews, vol. 26, no. 5, pp. 662–687, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Penna, A. Roncari, S. Amuchastegui et al., “Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3,” Blood, vol. 106, no. 10, pp. 3490–3497, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. C. Li, “Vitamin D regulation of the renin-angiotensin system,” Journal of Cellular Biochemistry, vol. 88, no. 2, pp. 327–331, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. K. C. Chiu, A. Chu, V. L. W. Go, and M. F. Saad, “Hypovitaminosis D is associated with insulin resistance and β cell dysfunction,” The American Journal of Clinical Nutrition, vol. 79, no. 5, pp. 820–825, 2004. View at Scopus
  32. A. Zittermann, “Vitamin D and disease prevention with special reference to cardiovascular disease,” Progress in Biophysics and Molecular Biology, vol. 92, no. 1, pp. 39–48, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. C. Li, A. E. Pirro, M. Amling et al., “Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 18, pp. 9831–9835, 1997. View at Scopus
  34. D. K. Panda, D. Miao, M. L. Tremblay et al., “Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 13, pp. 7498–7503, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. M. F. Holick and T. C. Chen, “Vitamin D deficiency: a worldwide problem with health consequences,” The American Journal of Clinical Nutrition, vol. 87, no. 4, pp. 1080S–1086S, 2008. View at Scopus
  36. A. C. Ross, J. E. Manson, S. A. Abrams et al., “The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know,” The Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 1, pp. 53–58, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Parker, O. Hashmi, D. Dutton et al., “Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis,” Maturitas, vol. 65, no. 3, pp. 225–236, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Deleskog, A. Hilding, K. Brismar, A. Hamsten, S. Efendic, and C. G. Ostenson, “Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance,” Diabetologia, vol. 55, pp. 1668–1678, 2012.
  39. N. G. Forouhi, Z. Ye, A. P. Rickard et al., “Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies,” Diabetologia, vol. 55, no. 8, pp. 2173–2182, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Mathieu and K. Badenhoop, “Vitamin D and type 1 diabetes mellitus: state of the art,” Trends in Endocrinology and Metabolism, vol. 16, no. 6, pp. 261–266, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Targher, L. Bertolini, R. Padovani et al., “Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients,” Clinical Endocrinology, vol. 65, no. 5, pp. 593–597, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. V. V. Borkar, V. S. Devidayal, and A. K. Bhalla, “Low levels of vitamin D in North Indian children with newly diagnosed type 1 diabetes,” Pediatric Diabetes, vol. 11, no. 5, pp. 345–350, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Takiishi, C. Gysemans, R. Bouillon, and C. Mathieu, “Vitamin D and diabetes,” Endocrinology and Metabolism Clinics of North America, vol. 39, no. 2, pp. 419–446, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Blanton, Z. Han, L. Bierschenk et al., “Reduced serum vitamin D-binding protein levels are associated with type 1 diabetes,” Diabetes, vol. 60, no. 10, pp. 2566–2570, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. E. J. Szathmary, “The effect of Gc genotype on fasting insulin level in Dogrib Indians,” Human Genetics, vol. 75, no. 4, pp. 368–372, 1987. View at Scopus
  46. S. Iyengar, R. F. Hamman, J. A. Marshall, P. P. Majumder, and R. E. Ferrell, “On the role of Vitamin D binding globulin in glucose homeostasis: results from the San Luis Valley Diabetes Study,” Genetic Epidemiology, vol. 6, no. 6, pp. 691–698, 1989. View at Scopus
  47. L. J. Baier, A. M. Dobberfuhl, R. E. Pratley, R. L. Hanson, and C. Bogardus, “Variations in the vitamin D-binding protein (Gc locus) are associated with oral glucose tolerance in nondiabetic Pima Indians,” The Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 8, pp. 2993–2996, 1998. View at Publisher · View at Google Scholar · View at Scopus
  48. M. Hirai, S. Suzuki, Y. Hinokio et al., “Group specific component protein genotype is associated with NIDDM in Japan,” Diabetologia, vol. 41, no. 6, pp. 742–743, 1998. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Hirai, S. Suzuki, Y. Hinokio et al., “Variations in vitamin D-binding protein (group-specific component protein) are associated with fasting plasma insulin levels in Japanese with normal glucose tolerance,” The Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 5, pp. 1951–1953, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. W. Z. Ye, D. Dubois-Laforgue, C. Bellanné-Chantelot, J. Timsit, and G. Velho, “Variations in the vitamin D-binding protein (Gc locus) and risk of type 2 diabetes mellitus in French Caucasians,” Metabolism, vol. 50, no. 3, pp. 366–369, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Klupa, M. Malecki, L. Hanna et al., “Amino acid variants of the vitamin D-binding protein and risk of diabetes in white Americans of European origin,” European Journal of Endocrinology, vol. 141, no. 5, pp. 490–493, 1999. View at Scopus
  52. A. W. Norman, B. J. Frankel, A. M. Heldt, and G. M. Grodsky, “Vitamin D deficiency inhibits pancreatic secretion of insulin,” Science, vol. 209, no. 4458, pp. 823–825, 1980. View at Scopus
  53. J. H. Faraco, N. A. Morrison, A. Baker, J. Shine, and P. M. Frossard, “ApaI dimorphism at the human vitamin D receptor gene locus,” Nucleic Acids Research, vol. 17, no. 5, article 2150, 1989. View at Scopus
  54. N. A. Morrison, R. Yeoman, P. J. Kelly, and J. A. Eisman, “Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphisms and circulating osteocalcin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 15, pp. 6665–6669, 1992. View at Publisher · View at Google Scholar · View at Scopus
  55. N. A. Morrison, Jian Cheng Qi, A. Tokita et al., “Prediction of bone density from vitamin D receptor alleles,” Nature, vol. 367, no. 6460, pp. 284–287, 1994. View at Publisher · View at Google Scholar · View at Scopus
  56. W. Z. Ye, A. F. Reis, and G. Velho, “Identification of a novel Tru9 I polymorphism in the human vitamin D receptor gene,” Journal of Human Genetics, vol. 45, no. 1, pp. 56–57, 2000. View at Scopus
  57. C. Gross, A. V. Krishnan, P. J. Malloy, T. R. Eccleshall, X. Y. Zhao, and D. Feldman, “The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants,” Journal of Bone and Mineral Research, vol. 13, no. 11, pp. 1691–1699, 1998. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Arai, K. I. Miyamoto, M. Yoshida et al., “The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene,” Journal of Bone and Mineral Research, vol. 16, no. 7, pp. 1256–1264, 2001. View at Scopus
  59. A. G. Uitterlinden, Y. Fang, J. B. J. Van Meurs, H. A. P. Pols, and J. P. T. M. Van Leeuwen, “Genetics and biology of vitamin D receptor polymorphisms,” Gene, vol. 338, no. 2, pp. 143–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. M. F. McDermott, A. Ramachandran, B. W. Ogunkolade et al., “Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians,” Diabetologia, vol. 40, no. 8, pp. 971–975, 1997. View at Publisher · View at Google Scholar · View at Scopus
  61. M. A. Pani, M. Knapp, H. Donner et al., “Vitamin D receptor allele combinations influence genetic susceptibility to 1 diabetes in Germans,” Diabetes, vol. 49, no. 3, pp. 504–507, 2000. View at Scopus
  62. T. J. Chang, H. H. Lei, J. I. Yeh et al., “Vitamin D receptor gene polymorphisms influence susceptibility to type 1 diabetes mellitus in the Taiwanese population,” Clinical Endocrinology, vol. 52, no. 5, pp. 575–580, 2000. View at Publisher · View at Google Scholar · View at Scopus
  63. J. Zhang, W. Li, J. Liu et al., “Polymorphisms in the vitamin D receptor gene and type 1 diabetes mellitus risk: an update by meta-analysis,” Molecular and Cellular Endocrinology, vol. 355, no. 1, pp. 135–142, 2012. View at Publisher · View at Google Scholar · View at Scopus
  64. J. Y. Oh and E. Barrett-Connor, “Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo study,” Metabolism, vol. 51, no. 3, pp. 356–359, 2002. View at Publisher · View at Google Scholar · View at Scopus
  65. G. A. Hitman, N. Mannan, M. F. McDermott et al., “Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians,” Diabetes, vol. 47, no. 4, pp. 688–690, 1998. View at Publisher · View at Google Scholar · View at Scopus
  66. M. T. Malecki, J. Frey, D. Moczulski, T. Klupa, E. Kozek, and J. Sieradzki, “Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population,” Experimental and Clinical Endocrinology and Diabetes, vol. 111, no. 8, pp. 505–509, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. W. Z. Ye, A. F. Reis, D. Dubois-Laforgue, C. Bellanné-Chantelot, J. Timsit, and G. Velho, “Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset,” European Journal of Endocrinology, vol. 145, no. 2, pp. 181–186, 2001. View at Scopus
  68. M. T. Malecki, T. Klupa, P. Wolkow, J. Bochenski, K. Wanic, and J. Sieradzki, “Association study of the vitamin D: 1Alpha-hydroxylase (CYP1alpha) gene and type 2 diabetes mellitus in a Polish population,” Diabetes and Metabolism, vol. 29, no. 2, pp. 119–124, 2003. View at Scopus
  69. J. M. Gelfand, B. A. C. Cree, J. McElroy et al., “Vitamin D in African Americans with multiple sclerosis,” Neurology, vol. 76, no. 21, pp. 1824–1830, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. D. L. Kamen, G. S. Cooper, H. Bouali, S. R. Shaftman, B. W. Hollis, and G. S. Gilkeson, “Vitamin D deficiency in systemic lupus erythematosus,” Autoimmunity Reviews, vol. 5, no. 2, pp. 114–117, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. L. L. Ritterhouse, S. R. Crowe, T. B. Niewold et al., “Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus,” Annals of the Rheumatic Diseases, vol. 70, no. 9, pp. 1569–1574, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. C. Mathieu and K. Badenhoop, “Vitamin D and type 1 diabetes mellitus: state of the art,” Trends in Endocrinology and Metabolism, vol. 16, no. 6, pp. 261–266, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. C. Mathieu and L. Adorini, “The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents,” Trends in Molecular Medicine, vol. 8, no. 4, pp. 174–179, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. D. M. Provvedini, C. D. Tsoukas, L. J. Deftos, and S. C. Manolagas, “1,25-Dihydroxyvitamin D3 receptors in human leukocytes,” Science, vol. 221, no. 4616, pp. 1181–1183, 1983. View at Scopus
  75. C. M. Veldman, M. T. Cantorna, and H. F. DeLuca, “Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system,” Archives of Biochemistry and Biophysics, vol. 374, no. 2, pp. 334–338, 2000. View at Publisher · View at Google Scholar · View at Scopus
  76. X. Dong, W. Lutz, T. M. Schroeder et al., “Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 44, pp. 16007–16012, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. G. Muthian, H. P. Raikwar, J. Rajasingh, and J. J. Bright, “1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNγ axis leading to Th1 response in experimental allergic encephalomyelitis,” Journal of Neuroscience Research, vol. 83, no. 7, pp. 1299–1309, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. P. T. Liu, S. Stenger, H. Li et al., “Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response,” Science, vol. 311, no. 5768, pp. 1770–1773, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Abdelsadik and A. Trad, “Toll-like receptors on the fork roads between innate and adaptive immunity,” Human Immunology, vol. 72, no. 12, pp. 1188–1193, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Hewison, “Vitamin D and the immune system: new perspectives on an old theme,” Endocrinology and Metabolism Clinics of North America, vol. 39, no. 2, pp. 365–379, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. D. D. Bikle, “Vitamin D and immune function: understanding common pathways,” Current Osteoporosis Reports, vol. 7, no. 2, pp. 58–63, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. A. K. Bhalla, E. P. Amento, B. Serog, and L. H. Glimcher, “1,25-dihydroxyvitamin D3 inhibits antigen-induced T cell activation,” Journal of Immunology, vol. 133, no. 4, pp. 1748–1754, 1984. View at Scopus
  83. K. A. Sterling, P. Eftekhari, M. Girndt, P. L. Kimmel, and D. S. Raj, “The immunoregulatory function of vitamin D: Implications in chronic kidney disease,” Nature Reviews Nephrology, vol. 8, no. 7, pp. 403–412, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. C. E. A. Chagas, M. C. Borges, L. A. Martini, and M. M. Rogero, “Focus on vitamin D, inflammation and type 2 diabetes,” Nutrients, vol. 4, no. 1, pp. 52–67, 2012. View at Publisher · View at Google Scholar · View at Scopus
  85. J. Fritsche, K. Mondal, A. Ehrnsperger, R. Andreesen, and M. Kreutz, “Regulation of 25-hydroxyvitamin D3-1α-hydroxylase and production of 1α,25-dihydroxyvitamin D3 by human dendritic cells,” Blood, vol. 102, no. 9, pp. 3314–3316, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. R. G. Baker, M. S. Hayden, and S. Ghosh, “NF-κB, inflammation, and metabolic disease,” Cell Metabolism, vol. 13, no. 1, pp. 11–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  87. M. Cohen-Lahav, S. Shany, D. Tobvin, C. Chaimovitz, and A. Douvdevani, “Vitamin D decreases NFκB activity by increasing IκBα levels,” Nephrology Dialysis Transplantation, vol. 21, no. 4, pp. 889–897, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. K. Sadeghi, B. Wessner, U. Laggner et al., “Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns,” European Journal of Immunology, vol. 36, no. 2, pp. 361–370, 2006. View at Publisher · View at Google Scholar · View at Scopus
  89. A. Giulietti, E. van Etten, L. Overbergh, K. Stoffels, R. Bouillon, and C. Mathieu, “Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D3 works as anti-inflammatory,” Diabetes Research and Clinical Practice, vol. 77, no. 1, pp. 47–57, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. D. Teegarden and S. S. Donkin, “Vitamin D: emerging new roles in insulin sensitivity,” Nutrition Research Reviews, vol. 22, no. 1, pp. 82–92, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. K. Tai, A. G. Need, M. Horowitz, and I. M. Chapman, “Vitamin D, glucose, insulin, and insulin sensitivity,” Nutrition, vol. 24, no. 3, pp. 279–285, 2008. View at Publisher · View at Google Scholar · View at Scopus
  92. C. Beaulieu, R. Kestekian, J. Havrankova, and M. Gascon-Barre, “Calcium is essential in normalizing intolerance to glucose that accompanies vitamin D depletion in vivo,” Diabetes, vol. 42, no. 1, pp. 35–43, 1993. View at Scopus
  93. J. N. Flanagan, L. Wang, V. Tangpricha, J. Reichrath, T. C. Chen, and M. F. Holick, “Regulation of the 25-hydroxyvitamin D-1alpha-hydroxylase gene and its splice variant,” Recent Results in Cancer Research, vol. 164, pp. 157–167, 2003. View at Scopus
  94. D. Zehnder, R. Bland, M. C. Williams et al., “Extrarenal expression of 25-hydroxyvitamin D3-1α-hydroxylase,” The Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 2, pp. 888–894, 2001. View at Publisher · View at Google Scholar · View at Scopus
  95. D. M. Thomas, S. D. Rogers, M. W. Sleeman et al., “Modulation of glucose transport by parathyroid hormone and insulin in UMR 106-01, a clonal rat osteogenic sarcoma cell line,” Journal of Molecular Endocrinology, vol. 14, no. 2, pp. 263–275, 1995. View at Scopus
  96. J. E. B. Reusch, N. Begum, K. E. Sussman, and B. Draznin, “Regulation of GLUT-4 phosphorylation by intracellular calcium in adipocytes,” Endocrinology, vol. 129, no. 6, pp. 3269–3273, 1991. View at Scopus
  97. A. F. Perna, G. Z. Fadda, X. J. Zhou, and S. G. Massry, “Mechanisms of impaired insulin secretion after chronic excess of parathyroid hormone,” American Journal of Physiology, vol. 259, no. 2, pp. F210–F216, 1990. View at Scopus
  98. M. Blum, G. Dolnikowski, E. Seyoum et al., “Vitamin D3 in fat tissue,” Endocrine, vol. 33, no. 1, pp. 90–94, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. S. Inomata, S. Kadowaki, and T. Yamatani, “Effect of 1α(OH)-vitamin D3 on insulin secretion in diabetes mellitus,” Bone and Mineral, vol. 1, no. 3, pp. 187–192, 1986. View at Scopus
  100. O. Gedik and S. Akalin, “Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man,” Diabetologia, vol. 29, no. 3, pp. 142–145, 1986. View at Scopus
  101. A. M. Borissova, T. Tankova, G. Kirilov, L. Dakovska, and R. Kovacheva, “The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients,” International Journal of Clinical Practice, vol. 57, no. 4, pp. 258–261, 2003. View at Scopus
  102. E. Orwoll, M. Riddle, and M. Prince, “Effects of vitamin D on insulin and glucagon secretion in non-insulin- dependent diabetes mellitus,” The American Journal of Clinical Nutrition, vol. 59, no. 5, pp. 1083–1087, 1994. View at Scopus
  103. A. V. G. Taylor and P. H. Wise, “Vitamin D replacement in Asians with diabetes may increase insulin resistance,” Postgraduate Medical Journal, vol. 74, no. 872, pp. 365–366, 1998. View at Scopus
  104. S. Ljunghall, L. Lind, H. Lithell et al., “Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance. A prospective randomized double-blind study,” Acta Medica Scandinavica, vol. 222, no. 4, pp. 361–367, 1987. View at Scopus
  105. S. Kumar, M. Davies, Y. Zakaria et al., “Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D,” Postgraduate Medical Journal, vol. 70, no. 824, pp. 440–443, 1994. View at Scopus
  106. B. Maestro, J. Campión, N. Dávila, and C. Calle, “Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells,” Endocrine Journal, vol. 47, no. 4, pp. 383–391, 2000. View at Scopus
  107. P. F. Williams, I. D. Caterson, G. J. Cooney, R. R. Zilkens, and J. R. Turtle, “High affinity insulin binding and insulin receptor-effector coupling: modulation by Ca2+,” Cell Calcium, vol. 11, no. 8, pp. 547–556, 1990. View at Publisher · View at Google Scholar · View at Scopus
  108. R. Riachy, B. Vandewalle, J. K. Conte et al., “1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20,” Endocrinology, vol. 143, no. 12, pp. 4809–4819, 2002. View at Publisher · View at Google Scholar · View at Scopus
  109. C. A. Gysemans, A. K. Cardozo, H. Callewaert et al., “1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice,” Endocrinology, vol. 146, no. 4, pp. 1956–1964, 2005. View at Publisher · View at Google Scholar · View at Scopus
  110. E. Van Etten and C. Mathieu, “Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts,” Journal of Steroid Biochemistry and Molecular Biology, vol. 97, no. 1-2, pp. 93–101, 2005. View at Publisher · View at Google Scholar · View at Scopus
  111. P. R. Von Hurst, W. Stonehouse, and J. Coad, “Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised, placebo-controlled trial,” British Journal of Nutrition, vol. 103, no. 4, pp. 549–555, 2010. View at Publisher · View at Google Scholar · View at Scopus